Vireo Growth (VREOF) Long-Term Deferred Tax (2020 - 2023)
Vireo Growth (VREOF) reported Long-Term Deferred Tax of $1.2 million for Q3 2023, down 78.08% on a YoY basis from $5.7 million in Q3 2022, and up 25.13% sequentially from $995000.0 in Q2 2023.
Vireo Growth (VREOF) Long-Term Deferred Tax (2020 - 2023) Analysis & Trends
Vireo Growth (VREOF) has 4 years of Long-Term Deferred Tax data on file, last reported at $1.2 million in Q3 2023.
- For the quarter ending Q3 2023, Long-Term Deferred Tax fell 78.08% year-over-year to $1.2 million; the trailing twelve-month figure through Sep 2023 stood at $1.2 million (down 78.08% YoY), and the FY2022 full-year result was $1.7 million, up 12.84% from the prior year.
- Long-Term Deferred Tax rose to $1.2 million in Q3 2023, from $995000.0 in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $5.7 million in Q3 2022 to a low of $157000.0 in Q4 2020.
- A 4-year average of $1.9 million and a median of $1.3 million in 2023 frame the typical range for Long-Term Deferred Tax.
- Across the five-year window, Long-Term Deferred Tax jumped 1585.46% in 2022 and slumped 78.08% in 2023, its largest moves.
- Tracing VREOF's Long-Term Deferred Tax over 4 years: stood at $157000.0 in 2020, then soared by 852.23% to $1.5 million in 2021, then gained by 12.84% to $1.7 million in 2022, then declined by 26.2% to $1.2 million in 2023.
- Business Quant data shows VREOF's Long-Term Deferred Tax at $1.2 million in Q3 2023, $995000.0 in Q2 2023, and $1.4 million in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 995,000.00 |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | 5.68 Mn |
| Jun 30, 2022 | 4.53 Mn |
| Mar 31, 2022 | 4.61 Mn |
| Dec 31, 2021 | 1.50 Mn |
| Sep 30, 2021 | 337,000.00 |
| Jun 30, 2021 | 367,000.00 |
| Mar 31, 2021 | 392,000.00 |
| Dec 31, 2020 | 157,000.00 |